HIF1A and neoplasm: Although the contribution of Hif1α to mediating resistance to radiation therapy varies between cell and tissue types [16], [20], it is now clear that increased Hif1α levels can have profound impacts on the sensitivity of both normal and tumor cells to cancer therapy.